Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × enfortumab vedotin × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 14 Urinary Bladder Neoplasms 8 Ureteral Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Neoplasm Metastasis 2 Advanced Bladder Cancer 2 Urogenital Neoplasms 1 Urethral Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Peripheral Nervous System Diseases 1 Penile Squamous Cell Carcinoma (PSCC) 1 Muscle-invasive Bladder Cancer 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Metastatic Urothelial Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Gemcitabine 8 Mitomycin 5 erdafitinib 4 dodecyl maltoside 4 Cystoscopy 3 Docetaxel 2 BCG Vaccine 2 pirarubicin 1 monalizumab 1 hydroxycamptothecinum 1 durvalumab 1 Transurethral Resection of Bladder 1 Patient Discharge 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Injections 1 Imiquimod 1 Epirubicin 1 Drainage 1 Clinical Trials, Phase II as Topic 1 Clinical Trials, Phase I as Topic 1 Accelerometry 1 5-aminolevulinic acid hexyl ester 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡